We are live on ! Find out more
GH icon

Guardant Health

397 hedge funds and large institutions have $7.73B invested in Guardant Health in 2025 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 134 increasing their positions, 133 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 37

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

9% more funds holding

Funds holding: 365 → 397 (+32)

1% more repeat investments, than reductions

Existing positions increased: 134 | Existing positions reduced: 133

2% less capital inflows, than outflows

Capital inflows: $1.02B | Capital outflows: $1.04B

10% less call options, than puts

Call options by funds: $156M | Put options by funds: $173M

1.08% less ownership

Funds ownership: 100.3% → 99.21% (-1.1%)

Holders
397
Holders Change
+32
Holders Change %
+8.77%
% of All Funds
5.18%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
71
Increased
134
Reduced
133
Closed
37
Calls
$156​M
Puts
$173​M
Net Calls
-⁠$16.8​M
Net Calls Change
+$20.6​M

GH Hedge Fund Activity: Q3 2025 in Review

397 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2025, worth a combined $7.73B — up 20% from $6.47B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new GH positions and 37 closed out — a net gain of 34 holders — while 134 added to existing stakes and 133 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $134M. The largest seller was Citadel Advisors, cutting an estimated $143M.

  • 397 institutional investors held Guardant Health (GH) as of Q3 2025, up from 365 in Q2 2025.
  • Funds reported $7.73B of Guardant Health stock for Q3 2025, up 20% quarter-over-quarter.
  • 71 funds opened new Guardant Health positions in Q3 2025 and 37 closed out, a net change of +34 holders.
  • The largest Guardant Health buyer in Q3 2025 was T. Rowe Price Associates, an estimated $134M added.
  • The largest Guardant Health seller in Q3 2025 was Citadel Advisors, an estimated $143M sold.

Based on aggregated 13F filings for Q3 2025.